Display options
Cite
Shojaie M, Rajpout MY, Abtahian A, et al. Dehydroepiandrosterone sulfate as a risk factor for premature myocardial infarction: a comparative study. Korean J Fam Med. 2015;36(1):1-9doi: 10.4082/kjfm.2015.36.1.1.
Shojaie, M., Rajpout, M. Y., Abtahian, A., Pour, A. E., Ghobadifar, M. A., & Akbarzadeh, A. (2015). Dehydroepiandrosterone sulfate as a risk factor for premature myocardial infarction: a comparative study. Korean journal of family medicine, 36(1), 1-9. https://doi.org/10.4082/kjfm.2015.36.1.1
Shojaie, Mohammad, et al. "Dehydroepiandrosterone sulfate as a risk factor for premature myocardial infarction: a comparative study." Korean journal of family medicine vol. 36,1 (2015): 1-9. doi: https://doi.org/10.4082/kjfm.2015.36.1.1
Shojaie M, Rajpout MY, Abtahian A, Pour AE, Ghobadifar MA, Akbarzadeh A. Dehydroepiandrosterone sulfate as a risk factor for premature myocardial infarction: a comparative study. Korean J Fam Med. 2015 Jan;36(1):1-9. doi: 10.4082/kjfm.2015.36.1.1. Epub 2015 Jan 31. PMID: 25780511; PMCID: PMC4360486.
Copy Download .nbib Format: NLM
Share it on

Korean J Fam Med. 2015 Jan;36(1):1-9. doi: 10.4082/kjfm.2015.36.1.1. Epub 2015 Jan 31.

Dehydroepiandrosterone sulfate as a risk factor for premature myocardial infarction: a comparative study.

Korean journal of family medicine

Mohammad Shojaie, Mohammad Yaghoub Rajpout, Armin Abtahian, Azadeh Esmail Pour, Mohamed Amin Ghobadifar, Armin Akbarzadeh

Affiliations

  1. Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran.
  2. Department of Internal Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.
  3. Department of Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
  4. Cardiac Care Unit Nurse, Peymanieh Hospital, Jahrom University of Medical Sciences, Jahrom, Iran.
  5. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 25780511 PMCID: PMC4360486 DOI: 10.4082/kjfm.2015.36.1.1

Abstract

BACKGROUND: This study aimed to evaluate some of the major risk factors of myocardial infarction including dehydroepiandrosterone sulfate in patients with premature myocardial infarction (age <50 years old) and myocardial infarction (age ≥50 years).

METHODS: This is a parallel case-control study on 50 premature myocardial infarction patients and 50 myocardial infarction patients. We also recruited 50 matched participants for each of the two groups. Patients and their control groups were assessed for dehydroepiandrosterone sulfate serum level, diabetes mellitus, hyperlipidemia, hypertriglyceridemia, and hypertension. In addition, family history of cardiovascular disease and current smoking was recorded. Univariate and multivariate logistic regression analyses were performed to evaluate predictors of premature myocardial infarction and myocardial infarction.

RESULTS: No significant differences were observed between the demographic data of patients and their controls. The dehydroepiandrosterone sulfate serum level was significantly higher in patients with premature myocardial infarction compared with controls. Multivariate logistic regression analysis revealed only serum dehydroepiandrosterone sulfate dehydroepiandrosterone sulfate level to be significantly associated with premature myocardial infarction (odds ratio, 2.65; 95% confidence interval, 1.44 to 4.877; P = 0.002). Additionally, hypertension was found to be associated with myocardial infarction.

CONCLUSION: Higher levels of serum dehydroepiandrosterone sulfate level are associated with premature myocardial infarction but not with myocardial infarction, and this association is independent of the effects of other risk factors.

Keywords: Dehydroepiandrosterone Sulfate; Myocardial Infarction; Risk Factors

References

  1. Int J Epidemiol. 2011 Feb;40(1):139-46 - PubMed
  2. Calcif Tissue Int. 2011 Oct;89(4):295-302 - PubMed
  3. Circulation. 2003 Oct 7;108(14):1688-93 - PubMed
  4. BMC Med. 2013 Apr 18;11:108 - PubMed
  5. Acta Cardiol. 1999 Oct;54(5):257-63 - PubMed
  6. Korean J Pain. 2012 Oct;25(4):245-53 - PubMed
  7. J Clin Epidemiol. 1999 Feb;52(2):95-103 - PubMed
  8. Eur J Pharmacol. 2011 Jun 25;660(2-3):268-74 - PubMed
  9. Pharmacol Ther. 2010 May;126(2):186-99 - PubMed
  10. Circulation. 2009 Sep 29;120(13):1231-40 - PubMed
  11. Arch Gerontol Geriatr. 2010 Jul-Aug;51(1):e16-8 - PubMed
  12. Endocrinol Metab Clin North Am. 2013 Jun;42(2):227-53 - PubMed
  13. J Renin Angiotensin Aldosterone Syst. 2015 Mar;16(1):137-44 - PubMed
  14. Chin Med J (Engl). 2012 Apr;125(7):1230-5 - PubMed
  15. J Sex Med. 2011 Nov;8(11):2960-82; quiz 2983 - PubMed
  16. Chest. 1995 Aug;108(2):364-9 - PubMed
  17. Gynecol Obstet Invest. 1987;23(4):271-4 - PubMed
  18. Circulation. 1994 Jan;89(1):89-93 - PubMed
  19. PLoS One. 2013 May 01;8(5):e63224 - PubMed
  20. Stroke. 2013 Jul;44(7):1784-9 - PubMed
  21. Age Ageing. 2010 Jul;39(4):451-8 - PubMed
  22. Orv Hetil. 2007 Apr 8;148(14):651-7 - PubMed
  23. Circulation. 1995 Mar 15;91(6):1757-60 - PubMed
  24. Clin Chem. 2008 Jul;54(7):1190-6 - PubMed
  25. Am J Cardiol. 2004 Oct 15;94(8):989-92 - PubMed
  26. N Engl J Med. 2005 Sep 15;353(11):1124-34 - PubMed
  27. J Clin Endocrinol Metab. 2010 Sep;95(9):4406-14 - PubMed
  28. Am J Epidemiol. 2001 Jan 1;153(1):79-89 - PubMed

Publication Types